Cover Image

A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients

Abstract Paclitaxel/platinum chemotherapy, the backbone of standard first‐line treatment of advanced non‐small cell lung cancer (NSCLC), exhibits high interpatient variability in treatment response and high toxicity burden. Baseline blood biomarker concentrations and tumor size (sum of diameters) at...

Full description

Saved in:

Bibliographic Details
Main Authors:	Francis Williams Ojara (Author), Andrea Henrich (Author), Nicolas Frances (Author), Yomna M. Nassar (Author), Wilhelm Huisinga (Author), Niklas Hartung (Author), Kimberly Geiger (Author), Stefan Holdenrieder (Author), Markus Joerger (Author), Charlotte Kloft (Author)
Format:	Book
Published:	Wiley, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bayesian Data Assimilation to Support Informed Decision Making in Individualized Chemotherapy
by: Corinna Maier, et al.
Published: (2020)

A continued learning approach for model‐informed precision dosing: Updating models in clinical practice
by: Corinna Maier, et al.
Published: (2022)

Reinforcement learning and Bayesian data assimilation for model‐informed precision dosing in oncology
by: Corinna Maier, et al.
Published: (2021)

Cell‐level systems biology model to study inflammatory bowel diseases and their treatment options
by: Sabine Stübler, et al.
Published: (2023)

Nonparametric goodness‐of‐fit testing for parametric covariate models in pharmacometric analyses
by: Niklas Hartung, et al.
Published: (2021)

Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
by: Undine Falkenhagen, et al.
Published: (2023)

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
by: Anna Mueller-Schoell, et al.
Published: (2021)

The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
by: Hong Zhao, et al.
Published: (2020)

Evaluation of Pegylated Liposomal Doxorubicin in the Treatment Of Both Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer
by: Hao Lin, et al.
Published: (2004)

Retraction Note: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
by: Hong Zhao, et al.
Published: (2021)

Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study
by: Ana‐Marija Grisic, et al.
Published: (2020)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023)

Off-label use of paclitaxel and pembrolizumab in a case of platinum refractory epithelial ovarian cancer and extensive thromboembolism
by: Clarissa Lam, et al.
Published: (2022)

Micturition symptoms in gynecologic cancer patients receiving paclitaxel and platinum-based chemotherapy regimen: a prospective study
by: Jongpeeti Wudtisan, et al.
Published: (2023)

Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents
by: Takatori Eriko, et al.
Published: (2012)

The platinum metals
by: Lumb, Arthur Douglas, -1938

The Prognostic Value of Baseline Lymphocyte, Neutrophil, and Monocyte Counts in Locally Advanced Cervical Carcinoma Treated with Radiation
by: Sareena Singh, et al.
Published: (2017)

Catalytic soot oxidation by platinum on sintered metal filters. Influence of the platinum quantity, particle size and location, and investigation of the platinum-soot contact
by: Hinot, Karelle
Published: (2007)

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance
by: Yin-Ting Chuang, et al.
Published: (2012)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
by: David Busse, et al.
Published: (2021)

Mirvetuximab after anaphylaxis to Paclitaxel: A case report
by: Megan A. Stewart, et al.
Published: (2024)

Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing-A Translational Example for Intensive Care Units
by: Ferdinand Anton Weinelt, et al.
Published: (2021)

GEMCITABINE / PLATINUM VS. VINORELBINE- PLATINUM IN PATIENTS WITH ADVANCED NON- SMALL- CELL LUNG CANCER
by: Deyan Davidov
Published: (2008)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023)

Airplane Boys at Platinum River
by: Craine, E. J. (Edith Janice), 1881-

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration
by: Yoontaek Lee, et al.
Published: (2024)

Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance
by: Takehiro Nakao, et al.
Published: (2024)

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
by: Cui Q, et al.
Published: (2021)

Sensory perception and kinetic relationship with Accuracy and the performance of the skills of handling and scoring football
by: Dr. Nassar Ismaeil M. Waleed Khalid
Published: (2020)

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen
by: Lena Klopp-Schulze, et al.
Published: (2020)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
by: Sally Mullany, et al.
Published: (2020)

Platinum preparations in the treatment of trophoblastic tumors
by: I. V. Markina, et al.
Published: (2014)

Are platinum nanoparticles safe to human health?
by: Ewelina Czubacka, et al.
Published: (2019)

Monofunctional Platinum(II) Anticancer Agents
by: Suxing Jin, et al.
Published: (2021)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
by: Lazzaro C, et al.
Published: (2013)

Paclitaxel-induced pseudoscleroderma
by: Krzysztof Sadko, et al.
Published: (2023)

The dark side of paclitaxel
by: Alekha K. Dash
Published: (2011)

Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
by: Felisiak-Golabek Anna, et al.
Published: (2011)

Increased Frataxin Expression Induced in Friedreich Ataxia Cells by Platinum TALE-VP64s or Platinum TALE-SunTag
by: Khadija Cherif, et al.
Published: (2018)